Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$1.6B |
| 2 |
Broadcom
AVGO
|
+$1.11B |
| 3 |
Invesco QQQ Trust
QQQ
|
+$882M |
| 4 |
JPMorgan Chase
JPM
|
+$628M |
| 5 |
Tesla
TSLA
|
+$594M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Honeywell
HON
|
+$1.54B |
| 2 |
Visa
V
|
+$1.39B |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.13B |
| 4 |
Amazon
AMZN
|
+$771M |
| 5 |
Berkshire Hathaway Class B
BRK.B
|
+$575M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.83% |
| 2 | Financials | 7.37% |
| 3 | Consumer Discretionary | 6.6% |
| 4 | Communication Services | 5.05% |
| 5 | Healthcare | 4.38% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ETNB
2151
DELISTED
89bio
ETNB
| $4.8M | ﹤0.01% |
488,711
-338,149
| -41% | -$2.8M |
|
2152
Cohen & Steers
CNS
$4.4B
| $4.8M | ﹤0.01% |
63,661
+17,776
| +39% | +$1.37M |
|
2153
Bio-Rad Laboratories Class A
BIO
$9.66B
| $4.79M | ﹤0.01% |
19,848
-10,001
| -34% | -$2.36M |
|
2154
Ring Energy
REI
$349M
| $4.78M | ﹤0.01% |
6,025,090
+5,876,012
| +3,942% | +$4.98M |
|
2155
Xenon Pharmaceuticals
XENE
$6.21B
| $4.78M | ﹤0.01% |
152,770
+133,500
| +693% | +$4.35M |
|
2156
Astera Labs
ALAB
$56B
| $4.78M | ﹤0.01% |
52,861
+46,919
| +790% | +$3.71M |
|
|
THS
2157
DELISTED
Treehouse Foods
THS
| $4.77M | ﹤0.01% |
245,743
-46,115
| -16% | -$1.03M |
|
2158
PUT
Sunrun
RUN
$2.37B
| $4.74M | ﹤0.01% |
+580,000
| New | +$4.56M |
|
|
APLS
2159
DELISTED
Apellis Pharmaceuticals
APLS
| $4.74M | ﹤0.01% |
273,912
+82,675
| +43% | +$1.53M |
|
2160
Pembina Pipeline
PBA
$28.4B
| $4.74M | ﹤0.01% |
126,383
-81,571
| -39% | -$3.08M |
|
2161
Beazer Homes USA
BZH
$874M
| $4.73M | ﹤0.01% |
211,276
+20,003
| +10% | +$415K |
|
2162
Enerpac Tool Group
EPAC
$1.89B
| $4.72M | ﹤0.01% |
116,443
+33,912
| +41% | +$1.43M |
|
2163
Full Truck Alliance
YMM
$9.2B
| $4.7M | ﹤0.01% |
397,773
+283,699
| +249% | +$3.3M |
|
2164
HUB Group
HUBG
$2.55B
| $4.7M | ﹤0.01% |
140,465
+37,033
| +36% | +$1.24M |
|
2165
Upwork
UPWK
$1.08B
| $4.69M | ﹤0.01% |
349,143
+174,710
| +100% | +$2.51M |
|
2166
JFrog
FROG
$11.5B
| $4.69M | ﹤0.01% |
106,855
-28,342
| -21% | -$1.08M |
|
2167
Customers Bancorp
CUBI
$2.82B
| $4.68M | ﹤0.01% |
79,733
+25,745
| +48% | +$1.3M |
|
2168
CALL
Granite Construction
GVA
$5.41B
| $4.68M | ﹤0.01% |
50,000
| – | – |
|
2169
Acadia Healthcare
ACHC
$2.82B
| $4.67M | ﹤0.01% |
206,021
+52,855
| +35% | +$1.25M |
|
2170
RXO
RXO
$3.85B
| $4.67M | ﹤0.01% |
297,355
+93,786
| +46% | +$1.42M |
|
2171
Phibro Animal Health
PAHC
$1.38B
| $4.67M | ﹤0.01% |
182,849
+14,215
| +8% | +$310K |
|
2172
NBT Bancorp
NBTB
$2.79B
| $4.66M | ﹤0.01% |
112,141
+30,759
| +38% | +$1.28M |
|
|
CRWV
2173
CALL
CoreWeave
CRWV
$58.6B
| $4.65M | ﹤0.01% |
+28,500
| New | +$2.63M |
|
2174
Hilltop Holdings
HTH
$2.28B
| $4.64M | ﹤0.01% |
153,035
+40,430
| +36% | +$1.2M |
|
2175
Comstock Resources
CRK
$3.99B
| $4.64M | ﹤0.01% |
167,828
+54,491
| +48% | +$1.24M |
|
Similar funds
Barclays's Q2 2025 Portfolio in Review
As of Q2 2025, Barclays held 5,681 positions worth $436B, up 24% from $353B the previous quarter. Its ten largest holdings account for 43% of the portfolio.
Barclays deployed $35.4B of net new capital in Q2 2025, opening 461 new positions and adding to 2,914 existing holdings. Its largest new stake was iShares MBS ETF: 4,310,047 shares worth $405M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 18% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was Honeywell, an estimated $1.54B trimmed.
- Barclays's largest Q2 2025 buy was iShares MBS ETF: 4,310,047 shares worth $405M.
- Barclays added most to NVIDIA in Q2 2025, an estimated $1.6B increase.
- Barclays's biggest Q2 2025 reduction was Honeywell, cutting an estimated $1.54B.
- Barclays fully exited Berry Global Group, Inc. in Q2 2025, selling an estimated $173M.
- Barclays's ten largest holdings make up 43% of its $436B portfolio in Q2 2025.
- Barclays opened 461 new positions and closed 463 in Q2 2025.
- Barclays's portfolio value rose 24% quarter-over-quarter to $436B.
Based on Barclays's 13F filing for Q2 2025, filed 13 Aug 2025.